Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
Top Cited Papers
Open Access
- 22 February 2007
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 356 (8), 775-789
- https://doi.org/10.1056/nejmoa063070
Abstract
Long-acting beta-agonists and inhaled corticosteroids are used to treat chronic obstructive pulmonary disease (COPD), but their effect on survival is unknown.Keywords
This publication has 21 references indexed in Scilit:
- Chronic obstructive pulmonary disease: current burden and future projectionsEuropean Respiratory Journal, 2006
- Epidemiology and costs of chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 2006
- The Effects of a Smoking Cessation Intervention on 14.5-Year MortalityAnnals of Internal Medicine, 2005
- The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2004
- Contemporary Management of Chronic Obstructive Pulmonary DiseasePublished by American Medical Association (AMA) ,2003
- Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysisThorax, 2003
- Chronic obstructive pulmonary diseaseThe Lancet, 2003
- A Randomized Trial Comparing Lung-Volume–Reduction Surgery with Medical Therapy for Severe EmphysemaNew England Journal of Medicine, 2003
- The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trialsAmerican Journal Of Medicine, 2002
- Continuous or Nocturnal Oxygen Therapy in Hypoxemic Chronic Obstructive Lung DiseaseAnnals of Internal Medicine, 1980